SMGIX vs. PNRAX
Compare and contrast key facts about Columbia Contrarian Core Fund (SMGIX) and Putnam Research Fund (PNRAX).
SMGIX is managed by Columbia Threadneedle. It was launched on Dec 14, 1992. PNRAX is managed by Putnam. It was launched on Oct 2, 1995.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SMGIX or PNRAX.
Correlation
The correlation between SMGIX and PNRAX is 0.95, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
SMGIX vs. PNRAX - Performance Comparison
Key characteristics
SMGIX:
0.99
PNRAX:
1.38
SMGIX:
1.24
PNRAX:
1.74
SMGIX:
1.22
PNRAX:
1.28
SMGIX:
1.29
PNRAX:
1.77
SMGIX:
5.46
PNRAX:
7.27
SMGIX:
2.77%
PNRAX:
2.75%
SMGIX:
15.39%
PNRAX:
14.59%
SMGIX:
-50.62%
PNRAX:
-61.03%
SMGIX:
-10.22%
PNRAX:
-8.87%
Returns By Period
In the year-to-date period, SMGIX achieves a 14.60% return, which is significantly lower than PNRAX's 19.34% return. Over the past 10 years, SMGIX has outperformed PNRAX with an annualized return of 11.81%, while PNRAX has yielded a comparatively lower 8.08% annualized return.
SMGIX
14.60%
-7.85%
-1.29%
15.01%
13.46%
11.81%
PNRAX
19.34%
-7.08%
1.88%
19.88%
9.92%
8.08%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SMGIX vs. PNRAX - Expense Ratio Comparison
SMGIX has a 0.75% expense ratio, which is lower than PNRAX's 1.03% expense ratio.
Risk-Adjusted Performance
SMGIX vs. PNRAX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Columbia Contrarian Core Fund (SMGIX) and Putnam Research Fund (PNRAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SMGIX vs. PNRAX - Dividend Comparison
Neither SMGIX nor PNRAX has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SMGIX Columbia Contrarian Core Fund | 0.00% | 0.58% | 0.57% | 0.49% | 0.78% | 1.08% | 1.35% | 0.95% | 0.91% | 2.86% | 0.74% | 0.75% |
PNRAX Putnam Research Fund | 0.00% | 0.28% | 1.14% | 0.00% | 0.59% | 0.98% | 0.42% | 0.00% | 1.06% | 1.19% | 0.98% | 0.69% |
Drawdowns
SMGIX vs. PNRAX - Drawdown Comparison
The maximum SMGIX drawdown since its inception was -50.62%, smaller than the maximum PNRAX drawdown of -61.03%. Use the drawdown chart below to compare losses from any high point for SMGIX and PNRAX. For additional features, visit the drawdowns tool.
Volatility
SMGIX vs. PNRAX - Volatility Comparison
Columbia Contrarian Core Fund (SMGIX) has a higher volatility of 10.04% compared to Putnam Research Fund (PNRAX) at 8.14%. This indicates that SMGIX's price experiences larger fluctuations and is considered to be riskier than PNRAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.